Healthcare provider profile · identity verified

Ye Wang, MD

General Practice · MAMARONECK, NY · NPI 1740393511

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Mirtazapine	Mirtazapine	578	44
Famotidine	Famotidine	550	61
Atorvastatin Calcium	Atorvastatin Calcium	495	39
Furosemide	Furosemide	474	43
Amlodipine Besylate	Amlodipine Besylate	465	40
Levothyroxine Sodium	Levothyroxine Sodium	423	26
Sertraline Hcl	Sertraline Hcl	368	22
Metoprolol Succinate	Metoprolol Succinate	339	29
Lisinopril	Lisinopril	329	17
Omeprazole	Omeprazole	324	39
Eliquis	Apixaban	306	26
Losartan Potassium	Losartan Potassium	275	19
Quetiapine Fumarate	Quetiapine Fumarate	251	15
Tamsulosin Hcl	Tamsulosin Hcl	237	21
Gabapentin	Gabapentin	225	17
Fluoxetine Hcl	Fluoxetine Hcl	170	suppressed
Levetiracetam	Levetiracetam	168	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	164	20
Citalopram Hbr	Citalopram Hydrobromide	148	suppressed
Latanoprost	Latanoprost	146	17
Carvedilol	Carvedilol	143	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	129	29
Paroxetine Hcl	Paroxetine Hcl	119	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	117	13
Divalproex Sodium	Divalproex Sodium	113	suppressed
Lactulose	Lactulose	108	18
Prednisone	Prednisone	107	16
Nystatin	Nystatin	101	31
Oseltamivir Phosphate	Oseltamivir Phosphate	98	76
Duloxetine Hcl	Duloxetine Hcl	91	suppressed
Donepezil Hcl	Donepezil Hcl	87	suppressed
Clopidogrel	Clopidogrel Bisulfate	81	suppressed
Pravastatin Sodium	Pravastatin Sodium	75	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	73	suppressed
Bupropion Xl	Bupropion Hcl	72	suppressed
Baclofen	Baclofen	71	suppressed
Levofloxacin	Levofloxacin	71	49
Finasteride	Finasteride	69	suppressed
Entresto	Sacubitril/Valsartan	68	suppressed
Methotrexate	Methotrexate Sodium	67	suppressed
Trazodone Hcl	Trazodone Hcl	66	suppressed
Ezetimibe	Ezetimibe	64	suppressed
Allopurinol	Allopurinol	60	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	59	suppressed
Risperidone	Risperidone	59	suppressed
Spironolactone	Spironolactone	59	suppressed
Metformin Hcl	Metformin Hcl	58	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	58	12
Jardiance	Empagliflozin	55	suppressed
Memantine Hcl	Memantine Hcl	55	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	54	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	52	20
Lorazepam	Lorazepam	48	17
Olanzapine	Olanzapine	45	suppressed
Potassium Chloride	Potassium Chloride	45	16
Triamcinolone Acetonide	Triamcinolone Acetonide	45	19
Montelukast Sodium	Montelukast Sodium	44	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	42	suppressed
Timolol Maleate	Timolol Maleate	42	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	39	suppressed
Hydrocortisone	Hydrocortisone	39	suppressed
Carvedilol Er	Carvedilol Phosphate	38	suppressed
Clozapine	Clozapine	38	suppressed
Meclizine Hcl	Meclizine Hcl	38	suppressed
Carbamazepine	Carbamazepine	37	suppressed
Doxepin Hcl	Doxepin Hcl	37	suppressed
Meloxicam	Meloxicam	37	19
Aripiprazole	Aripiprazole	36	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	21
Rexulti	Brexpiprazole	36	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	13
Ssd	Silver Sulfadiazine	34	21
Atenolol	Atenolol	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Simvastatin	Simvastatin	32	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	30	suppressed
Incruse Ellipta	Umeclidinium Bromide	30	suppressed
Ketoconazole	Ketoconazole	30	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	30	12
Memantine Hcl Er	Memantine Hcl	29	suppressed
Nystop	Nystatin	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Austedo	Deutetrabenazine	26	suppressed
Clonidine	Clonidine	26	suppressed
Desmopressin Acetate	Desmopressin Acetate	26	suppressed
Elmiron	Pentosan Polysulfate Sodium	26	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	26	suppressed
Tetrabenazine	Tetrabenazine	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Leucovorin Calcium	Leucovorin Calcium	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	21
Trexall	Methotrexate Sodium	25	suppressed
Amoxicillin	Amoxicillin	24	suppressed
Mupirocin	Mupirocin	24	suppressed
Ramipril	Ramipril	24	suppressed
Scopolamine	Scopolamine	24	suppressed
Azithromycin	Azithromycin	23	20
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Methimazole	Methimazole	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Cephalexin	Cephalexin	20	suppressed
Digoxin	Digoxin	20	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Insulin Aspart Flexpen	Insulin Aspart	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	12
Fluconazole	Fluconazole	17	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	17	suppressed
Sodium Chloride	0.9 % Sodium Chloride	16	14
Breyna	Budesonide/Formoterol Fumarate	15	suppressed
Vraylar	Cariprazine Hcl	15	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	12
Verapamil Er	Verapamil Hcl	13	suppressed
Cefuroxime	Cefuroxime Axetil	12	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Temazepam	Temazepam	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	11	suppressed
Bicalutamide	Bicalutamide	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error